Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Arcutis Biotherapeutics, Inc. | Chief Financial Officer | Common Stock | 158K | $1.5M | $9.48 | Sep 24, 2024 | Direct |
Arcutis Biotherapeutics, Inc. | Chief Financial Officer | Stock Option (right to buy) | 310K | Apr 10, 2024 | Direct | ||
Frazier Lifesciences Acquisition Corp | Chief Financial Officer, Director | Class B Ordinary Shares | 0 | Nov 22, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARQT | Arcutis Biotherapeutics, Inc. | Sep 21, 2024 | 2 | -$110K | 4 | Sep 25, 2024 | Chief Financial Officer |
ARQT | Arcutis Biotherapeutics, Inc. | Apr 10, 2024 | 2 | $0 | 4 | Apr 11, 2024 | Chief Financial Officer |
ARQT | Arcutis Biotherapeutics, Inc. | Apr 10, 2024 | 0 | $0 | 3 | Apr 11, 2024 | Chief Financial Officer |
FLAC | Frazier Lifesciences Acquisition Corp | Nov 22, 2022 | 1 | $0 | 4 | Nov 23, 2022 | Chief Financial Officer, Director |